Medtronic Comes Under Fire for Flawed Study


Doctor's hired to study the safety of Medtronic's Infuse Bone Graft found to have significant financial ties to the company, calling into question the safety of the product. Medtronic is now paying $2.5 million to an independent researcher to determine whether the product is safe for the public.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© TorHoerman Law, LLC | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »